B. Braun Medical Inc. recalled 23,100 containers of 0.9% Sodium Chloride Injection on August 4, 2025. The recall stems from a lack of assurance of sterility and potential fluid leakage. This product is distributed nationwide in the United States.
Lack of Assurance of Sterility; potential for fluid leakage at one of the weld sites.
Consumers and healthcare providers should stop using this product immediately. Contact B BRAUN MEDICAL INC or your healthcare provider for guidance. Notification method: Letter
The recalled product is 0.9% Sodium Chloride Injection USP, L 8000, in a 1000mL Excel Container. It is a prescription-only, sterile, nonpyrogenic, single-dose container. The affected lot number is J5C919, with an expiration date of August 31, 2027.
The recall is due to a lack of assurance of sterility and the potential for fluid leakage at one of the weld sites. These issues pose health risks, particularly for patients who rely on sterile injections.
No specific incidents or injuries have been reported in connection with this recall as of the report date.
Stop using the recalled product immediately. Contact B. Braun Medical Inc. or your healthcare provider for guidance on how to proceed. Notifications have been sent via letter.
For further information, contact B. Braun Medical Inc. at their official website or customer service number.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.